[ 3 ] Janus CL, Wivzky HP, Laufer N. Mangnetic resonance of the menstrual cycle[J]. Magn Reson Imaging, 1988, 6(3): 669-674.
[2]
[ 4 ] Hardesty LA, Sumkin JH, Nath ME, et al. Use of preoperative MR imaging in the management of endometrial carcinoma: cost-analysis[J]. Radiology, 2000, 215(1): 45-49.
[3]
[ 5 ] Walsh JW. Computed tomography of gynecologic neoplasms[J]. Radiol Clini North Am, 1992, 30(4): 817-830.
[4]
[ 6 ] 成令忠. 组织学[M]. 2版.北京: 人民卫生出版社, 1993: 1427.
[5]
[ 7 ] 乐 杰.妇产科学[M].4版.北京: 人民卫生出版社, 1997: 293-295.
[6]
[ 1 ] Kinkel LA, Kaji Y, Kyle KY, et al. Radiologic staging in patients with endometrial cancer: A Meta?analysis[J]. Radiology, 1999, 212(3): 711-718.
Torricelli P, Ferraresi S, Fiocchi F, et al. 3-T MRI in the preoperative evaluation of depth of myometrial infiltration in endometrial cancer[J]. AJR Am J Roentgenol, 2008, 190(2): 489-495.
Sala E, Crawford R, Senior E, et al. Added value of dynamic contrast-enhanced magnetic resonance imaging in predicting advanced stage disease in patients with endometrial carcinoma[J]. Int J Gynecol Cancer, 2009, 19(1): 141-6.
[15]
Kitajima K, Murakami K, Yamasaki E, et al. Accuracy of 18F-FDG PET/CT in detecting pelvic and paraaortic lymph node metastasis in patient with endometrial cancer[J]. AJR Am J Roentgenol, 2008, 190(6): 1652-8.
[16]
Lee SI, Russell AH. Performance of 18F-FDG PET/CT in endometrial cancer[J]. AJR Am J Roentgenol, 2008, 191(5): W210.